Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients

Molecular Oncology
Sharon K Huang, Dave S B Hoon

Abstract

Cutaneous melanoma is one of the highest incident-rate cancers with increasing prevalence in Western societies. Despite the advent of new approved therapeutics, the 5-year overall survival rate of stage IV melanoma patients remains below 15%. Current treatments for late stage disease have shown higher efficacy when treated at a lower disease burden. Thus, blood-based biomarkers capable of detecting melanoma prior to clinically evident distant metastasis, will improve the treatment and outcomes for melanoma patients. To that end, effective treatment of melanoma necessitates identification of patients at risk for developing distant metastases. Furthermore, employing blood biomarkers that monitor cancer progression over the course of treatment is a promising solution to post-treatment drug resistance often developed in melanoma patients. Non-invasive blood biomarker assays allow for regular dynamic monitoring of disease. "Liquid Biopsy" of blood, which exploits circulating tumor cells (CTCs), cell-free circulating tumor DNA (ctDNA) and cell-free circulating microRNA (cmiRNA), has been shown to detect prognostic factors for relapse in AJCC stage III and stage IV melanoma patients. Moreover, molecular characterization of CTC and ana...Continue Reading

References

Apr 27, 2005·Nature Reviews. Molecular Cell Biology·V Narry Kim
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kazuo KoyanagiDave S B Hoon
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Takuji MoriDave S B Hoon
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles R ScogginsKelly M McMasters
Jul 5, 2006·Cancer Research·Takuji MoriDave S B Hoon
Sep 12, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naoyuki UmetaniDave S B Hoon
Feb 23, 2007·International Journal of Cancer. Journal International Du Cancer·Maria DaniottiMonica Rodolfo
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masaru ShinozakiDave S B Hoon
Jul 10, 2009·The Journal of Investigative Dermatology·Yasufumi GotoDave S B Hoon
Oct 2, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Alberto FusiUlrich Keilholz
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Apr 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kazuo KoyanagiDave S B Hoon
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jan 29, 2011·Journal of Dermatological Science·Hisashi KanemaruHironobu Ihn
May 13, 2011·Nature Reviews. Cancer·Heidi SchwarzenbachKlaus Pantel
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Aug 16, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Pamela PinzaniClaudio Orlando
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Mar 10, 2012·The Journal of Investigative Dermatology·Sojun HoshimotoDave S B Hoon
Jul 24, 2012·Nature Biotechnology·Daniel RamsköldRickard Sandberg
Aug 4, 2012·Journal of Translational Medicine·Erica B FriedmanIman Osman
Sep 26, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sojun HoshimotoDave S B Hoon
Dec 5, 2012·PloS One·Francesca SalviantiClaudio Orlando
Dec 12, 2012·The Journal of Investigative Dermatology·Leila KhojaCaroline Dive
Jan 11, 2013·The Journal of Investigative Dermatology·Gerald SaldanhaJ Howard Pringle
Feb 15, 2013·The Journal of Investigative Dermatology·Cristiana Lo NigroTim Crook
Aug 2, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Eyal GreenbergGal Markel
Oct 17, 2013·Expert Review of Molecular Diagnostics·Diego M MarzeseDave S B Hoon
Feb 5, 2014·Nature Reviews. Clinical Oncology·Heidi SchwarzenbachKlaus Pantel
Feb 18, 2014·Critical Reviews in Oncology/hematology·Stefan RodicRamy R Saleh

❮ Previous
Next ❯

Citations

Aug 25, 2016·Virchows Archiv : an International Journal of Pathology·Paul Hofman, Helmut H Popper
May 1, 1997·Mayo Clinic Proceedings·M H Greene
Apr 28, 2017·Biomolecular Concepts·Virginie Armand-Labit, Anne Pradines
Jul 9, 2017·Cancer Letters·Leslie CalapreElin S Gray
Feb 18, 2018·Proceedings of the National Academy of Sciences of the United States of America·Xin HongDaniel A Haber
Jul 26, 2018·Plastic and Reconstructive Surgery·Thomas KnackstedtBrian Gastman
Aug 7, 2018·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Yifang LeeAli Asgar Bhagat
Oct 27, 2018·Journal of Cellular Physiology·Ali MohammadpourMohammad Momeni
Oct 22, 2018·Immunogenetics·Laura Santambrogio, Hans-Georg Rammensee
Nov 21, 2018·Future Oncology·Rebecca W KnackstedtBrian Gastman
Nov 18, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Liang ChengRodolfo Montironi
Dec 8, 2019·Clinical Chemistry·Luis Enrique Cortés-HernándezCatherine Alix-Panabières
Nov 12, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·B Sánchez-SendraC Monteagudo
Apr 13, 2019·The Journal of Experimental Medicine·Maria A S BroggiMelody A Swartz
Sep 17, 2019·Cancer Biomarkers : Section a of Disease Markers·Francesca SalviantiPamela Pinzani
Mar 19, 2020·Frontiers in Cell and Developmental Biology·Monica NeaguSabina Zurac
Jan 4, 2017·BioMed Research International·Stefan HoldenriederFarshid Dayyani
Nov 16, 2018·International Journal of Molecular Medicine·Chao CiWei Ding
Aug 23, 2019·Biomicrofluidics·Florina S IliescuCiprian Iliescu
Sep 1, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Channay NaidooHeidi Abrahamse
Jul 8, 2018·Clinical & Experimental Metastasis·Catherine Alix-Panabières, Klaus Pantel
Apr 17, 2020·Cancers·Magali BoyerCatherine Alix-Panabières
Jul 22, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mathieu ChicardGudrun Schleiermacher
Nov 27, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Swathi MeruguDeborah A Tweddle
Sep 10, 2020·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Tomasz KolendaKatarzyna Lamperska
May 1, 2021·Journal of Personalized Medicine·Alicia BaumgartnerJohannes Gojo
May 30, 2021·Journal of Dermatological Science·Akira KanekoHironobu Ihn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Clinical Chemistry
Catherine Alix-Panabières, Klaus Pantel
Zhongguo fei ai za zhi = Chinese journal of lung cancer
Hui LiYing Cheng
Genome Medicine
Ellen HeitzerMichael R Speicher
Bulletin du cancer
Catherine Alix-Panabières, Jean-Yves Pierga
© 2022 Meta ULC. All rights reserved